Evidence map›Paper›PMID 35095827›Full record

ArticleFrontiers in microbiology2021

Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia.

Paolo Malune, Giovanna Piras, Maria Monne, Maura Fiamma, Rosanna Asproni, Tatiana Fancello, Antonio Manai, Franco Carta, Giovanna Pira, Patrizia Fancello and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Paolo MaluneUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Giovanna PirasUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Maria MonneUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Maura FiammaUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Rosanna AsproniUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Tatiana FancelloUOC Cardiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Antonio ManaiUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Franco CartaUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Giovanna PiraUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Patrizia FancelloUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Valentina RosuUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Antonella UrasUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Caterina MereuUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Giuseppe MameliUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Iana Lo MaglioUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Maria Cristina GarauUOC Laboratorio Analisi Clinico-Chimiche e Microbiologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Angelo Domenico PalmasUOC Ematologia, P.O. "San Francesco," Azienda Tutela Salute, ASSL Nuoro, Nuoro, Italy.
Associazione Istituzione Libera Università Nuorese · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe SARS-CoV-2 pandemic stimulated an outstanding global sequencing effort, which allowed to monitor viral circulation and evolution. Nuoro province (Sardinia, Italy), characterized by a relatively isolated geographical location and a low population density, was severely hit and displayed a high incidence of infection.

methodsAmplicon approach Next Generation Sequencing and subsequent variant calling in 92 respiratory samples from SARS-CoV-2 infected patients involved in infection clusters from March 2020 to May 2021.

resultsPhylogenetic analysis displayed a coherent distribution of sequences in terms of lineage and temporal evolution of pandemic. Circulating lineage/clade characterization highlighted a growing diversity over time, with an increasingly growing number of mutations and variability of spike and nucleocapsid proteins, while viral RdRp appeared to be more conserved. A total of 384 different mutations were detected, of which 196 were missense and 147 synonymous ones. Mapping mutations along the viral genome showed an irregular distribution in key genes.

conclusionThe analysis of the 92 viral genome highlighted evolution over time and identified which mutations are more widespread than others. The high number of sequences also permits the identification of subclusters that are characterized by subtle differences, not only in terms of lineage, which may be used to reconstruct transmission clusters. The disclosure of viral genetic diversity and timely identification of new variants is a useful tool to guide public health intervention measures.

Indexed as

COVID-19epidemiologygenome sequencingmolecular characterizationpandemic (COVID-19)phylogenySardinia—ItalySARS-CoV-2

Identifiers

PMID35095827
PMCPMC8795702
OpenAlexW4205236595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.